| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 55.49B | 55.47B | 56.97B | 60.95B | 53.56B | 40.93B |
| Gross Profit | 8.95B | 23.11B | 21.98B | 14.38B | 14.02B | 12.72B |
| EBITDA | 11.88B | 12.16B | 11.88B | 12.34B | 10.42B | 11.34B |
| Net Income | 5.64B | 5.71B | 6.18B | 5.36B | 5.13B | 6.12B |
Balance Sheet | ||||||
| Total Assets | 162.42B | 158.27B | 161.98B | 168.47B | 168.07B | 150.28B |
| Cash, Cash Equivalents and Short-Term Investments | 9.79B | 7.69B | 10.41B | 13.36B | 10.63B | 7.83B |
| Total Debt | 62.06B | 58.81B | 56.91B | 60.44B | 55.92B | 43.03B |
| Total Liabilities | 93.50B | 89.94B | 90.96B | 95.71B | 88.61B | 73.51B |
| Stockholders Equity | 57.61B | 57.39B | 59.85B | 63.61B | 69.81B | 66.76B |
Cash Flow | ||||||
| Free Cash Flow | 3.95B | 2.54B | 2.50B | 1.40B | 2.20B | 3.29B |
| Operating Cash Flow | 9.75B | 9.00B | 10.93B | 9.73B | 10.62B | 10.58B |
| Investing Cash Flow | -2.06B | -2.31B | -2.50B | -8.41B | -13.47B | -8.17B |
| Financing Cash Flow | -8.05B | -9.21B | -12.45B | 1.91B | 5.39B | -3.01B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | HK$77.12B | 12.05 | 13.36% | 4.30% | -3.19% | -2.68% | |
75 Outperform | HK$49.40B | 16.34 | 7.17% | 4.43% | -4.37% | -41.14% | |
66 Neutral | HK$41.73B | 14.71 | 4.98% | 6.44% | -2.28% | -9.61% | |
66 Neutral | $17.65B | 18.10 | 5.60% | 3.62% | 6.62% | 11.55% | |
65 Neutral | $132.49B | 23.51 | 9.86% | 4.94% | 0.36% | 2.55% | |
61 Neutral | HK$13.40B | 7.82 | 6.98% | 6.38% | 3.86% | 30.34% | |
48 Neutral | HK$7.59B | 49.73 | 2.04% | 0.71% | -7.82% | -38.06% |